| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | IGMS | Common Stock | Award | $4,533 | +353 | +1% | $12.84 | 34,051 | 15 Nov 2022 | Direct | F1 |
| transaction | IGMS | Common Stock | Sale | $12,826 | -600 | -1.8% | $21.38 | 33,451 | 23 Nov 2022 | Direct | F2, F3 |
| transaction | IGMS | Common Stock | Sale | $6,092 | -277 | -0.83% | $21.99 | 33,174 | 23 Nov 2022 | Direct | F2, F4 |
| Id | Content |
|---|---|
| F1 | The shares were acquired under the IGM Biosciences, Inc. 2019 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). |
| F2 | These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units. |
| F3 | This transaction was executed in multiple trades at prices ranging from $20.74 to $21.73. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| F4 | This transaction was executed in multiple trades at prices ranging from $21.74 to $22.44. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |